Product Description
Bemotrizinol, or bis-ethylhexyloxyphenol methoxyphenyl triazine, is an organic UV filter found in over-the-counter sunscreen products. It primarily absorbs UV-A rays. (Sourced from: https://pubchem.ncbi.nlm.nih.gov/compound/Bemotrizinol)
Mechanisms of Action: No Mechanism
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Topical
FDA Designation: None *
Approval Status: Not Approved
Approved Countries: Australia | Canada | India
Approved Indications: None
Known Adverse Events: None
Company: DSM Nutritional Products
Company Location:
Company CEO:
Additonal Commercial Interests: None
Clinical Description
Countries in Clinic: United States
Active Clinical Trial Count: 4
Highest Development Phases
Phase 3: Croup
Phase 2: Animal Hypersensitivity|Environmental Hypersensitivity|Erythema|Sunburn
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
|---|---|---|---|---|---|
| MUsT | P3 |
Completed |
Croup |
2022-10-28 |
86% |
| DSM PA 2020 | P2 |
Completed |
Environmental Hypersensitivity|Erythema|Animal Hypersensitivity |
2022-04-22 |
32% |
| DSM RIPT 2020 | P2 |
Completed |
Sunburn |
2022-04-08 |
24% |
| DSM PT 2020 | P2 |
Completed |
Erythema |
2022-03-03 |
32% |